Microencapsulation via Wax Phase Transition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microencapsulation processes face challenges in controlling particle size, achieving energy efficiency, and maintaining product characteristics, particularly for applications requiring particle sizes less than 50 micrometers, and often involve chemical reactions or energy-intensive methods.

Innovation Solution

A process involving heating a fatty phase with wax and an active ingredient, then forming a stable oil-in-water emulsion with a water-soluble surfactant and protective colloid, followed by dropwise addition into a second aqueous phase at a lower temperature to create microcapsules with controlled size between 2 and 80 micrometers, without chemical reactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If conventional microencapsulation processes are used, then chemical reactions or energy-intensive methods are involved, but this increases environmental impact and process complexity

Engineering Contradiction:
Improveenvironmental impactVSAvoidprocess complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates chemical reactions from the microencapsulation process, using purely physical phase transition mechanisms instead. This removes harmful chemical factors while maintaining encapsulation functionality through wax melting and solidification cycles.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The process utilizes temperature parameter changes to control wax phase transitions. By cycling temperature above and below the wax melting point, the system achieves encapsulation and release without chemical reactions, reducing environmental impact while simplifying the process.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If particle size control is achieved through conventional methods, then energy-intensive procedures are required, but this increases energy consumption

Engineering Contradiction:
Improveparticle size controlVSAvoidenergy consumption
Core Design Contradiction:
Manufacturing precisionVSUse of energy by moving object

Solution Approach 1:

The invention employs phase transitions of the wax material as the core mechanism for particle formation and size control. The wax melts at elevated temperature allowing emulsion formation, then solidifies upon cooling to define particle size, eliminating the need for energy-intensive mechanical size reduction methods.

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The process replaces mechanical size control methods (such as milling or homogenization) with a thermal-field-based approach. Temperature-controlled phase transitions naturally define particle dimensions during the encapsulation process, significantly reducing energy consumption while maintaining precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Duration of action of stationary object

If microcapsules are produced for long-lasting release applications, then specific technologies are required, but this increases device complexity

Engineering Contradiction:
Improverelease durationVSAvoidtechnology complexity
Core Design Contradiction:
Duration of action of stationary objectVSDevice complexity

Solution Approach 1:

The invention uses the phase transition properties of the wax matrix to control active ingredient release duration. The wax remains solid at use temperature, providing a stable matrix for long-lasting release, and melts at elevated temperature to enable controlled discharge, achieving extended duration without complex multi-layer structures.

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The process creates composite microcapsules combining a wax matrix with encapsulated active ingredient. This composite structure provides both the structural integrity needed for long-term stability and the thermal-responsive release mechanism, achieving extended duration in a relatively simple single-phase system.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the production of microcapsules with precise size control, improved stability, and reduced energy consumption, enabling their use in various applications such as cosmetics and agrochemicals while minimizing environmental impact.

Implementation Method 1

heating a fatty phase with wax and an active ingredient

Methodology Applied
Scientific EffectMelting: Melting

Implementation Method 2

cold crystallization step

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Data Source

PatentEP2894978B1Alternative method for microencapsulation of active ingredients
Publication Date: 2018.07.18 CREATHES
  • EP2894978B1 patent drawingFigure 1~4
  • EP2894978B1 patent drawingFigure 5~6
  • EP2894978B1 patent drawingFigure 7~8

AI summary

The present invention relates to a method for producing a dispersion of microcapsules of active ingredient, in suspension in water, comprising the following successive steps: heating a fatty phase comprising at least (i) a wax, and at least one active ingredient to be encapsulated, at a reaction temperature above the melting point of said wax; heating a first aqueous phase comprising at least one water-soluble surfactant and at least one protective colloid; incorporating said fatty phase into said first aqueous phase while maintaining the reaction temperature, so as to form a stable oil-in-water emulsion; adding, dropwise, said emulsion previously formed to a second aqueous phase comprising at least one water-soluble surfactant, the temperature of said second phase being below the melting point of said wax and resulting in the formation of solid crystalline microcapsules containing said active ingredient, said microcapsules being in suspension in said second aqueous phase. The invention also relates to the use of the microcapsules obtained at the end of the process, (i) for producing a cosmetic composition or (ii) for producing impregnated fabrics or (iii) for producing household products.